EUVIMEDAvasta EUVIMED
Übersichtsarbeit

Targeting epidermal growth factor receptor and its downstream signaling pathways by natural products: A mechanistic insight

Rutuja Damare, Kritika Engle, Gautam Kumar iD

Phytotherapy Research · 2024-05 · 38 (5) · 2406-2447

DOI: 10.1002/ptr.8166 ↗

At a glance

Übersichtsarbeit in Phytotherapy Research, published online on 2024-03-03. Written by Rutuja Damare and 2 co-authors. Institution: Department of Natural Products, Chemical Sciences, National Institute of Pharmaceutical Education and Research-Hyderabad, Hyderabad, India. Major MEDLINE topics: ErbB Receptors, Signal Transduction, Biological Products, Neoplasms. Cited 33 times so far (Crossref); 221 references.

AbstraktSubjectsBibliograafilised andmedCiteRelated studies

Abstract (original language)

The epidermal growth factor receptor (EGFR) is a transmembrane receptor tyrosine kinase (RTK) that maintains normal tissues and cell signaling pathways. EGFR is overactivated and overexpressed in many malignancies, including breast, lung, pancreatic, and kidney. Further, the EGFR gene mutations and protein overexpression activate downstream signaling pathways in cancerous cells, stimulating the growth, survival, resistance to apoptosis, and progression of tumors. Anti‐EGFR therapy is the potential approach for treating malignancies and has demonstrated clinical success in treating specific cancers. The recent report suggests most of the clinically used EGFR tyrosine kinase inhibitors developed resistance to the cancer cells. This perspective provides a brief overview of EGFR and its implications in cancer. We have summarized natural products‐derived anticancer compounds with the mechanistic basis of tumor inhibition via the EGFR pathway. We propose that developing natural lead molecules into new anticancer agents has a bright future after clinical investigation.

Subjects

MeSH terms (MEDLINE)

ErbB ReceptorsSignal TransductionBiological ProductsNeoplasmsHumansProtein Kinase InhibitorsAntineoplastic AgentsAnimals

Author keywords

EGFREGFR PathwaysSecondary metabolitesbreast cancercancerdrug resistancelung cancertyrosine kinase

Substances

ErbB ReceptorsBiological ProductsProtein Kinase InhibitorsAntineoplastic AgentsEGFR protein, human

Authors and institutions

  • Department of Natural Products, Chemical Sciences, National Institute of Pharmaceutical Education and Research-Hyderabad, Hyderabad, India.

ORCID profiles: Gautam Kumar

Cite

APA

Damare, R., Engle, K., & Kumar, G. (2024). Targeting epidermal growth factor receptor and its downstream signaling pathways by natural products: A mechanistic insight. Phytotherapy Research, 38(5), 2406-2447. https://doi.org/10.1002/ptr.8166

Vancouver

Damare R, Engle K, Kumar G. Targeting epidermal growth factor receptor and its downstream signaling pathways by natural products: A mechanistic insight. Phytotherapy Research. 2024;38(5):2406-2447. doi:10.1002/ptr.8166

BibTeX
@article{Damare2024,
  author = {Damare, Rutuja and Engle, Kritika and Kumar, Gautam},
  title = {Targeting epidermal growth factor receptor and its downstream signaling pathways by natural products: A mechanistic insight},
  journal = {Phytotherapy Research},
  year = {2024},
  volume = {38},
  number = {5},
  pages = {2406--2447},
  doi = {10.1002/ptr.8166}
}
Start for free →